Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol with electric cardioversion vs nebivolol alone in tachycardia-induced LV dysfunction
2004-004864-54Phase 3Completed
- Sponsor
- Berlin-Chemie AG
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nebivolol in hypertension (HTN), left ventricular dysfunction and tachyarrhythmia (2 arms), sponsored by Berlin-Chemie AG. Primary endpoint: Change in left ventricular end-diastolic diameter (LVEDD). Started Sep 2005; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)left ventricular dysfunctiontachyarrhythmia
Beyond the preview
Go deeper on 2004-004864-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004864-54.